Literature DB >> 9506641

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.

A B Moscicki1, S Shiboski, J Broering, K Powell, L Clayton, N Jay, T M Darragh, R Brescia, S Kanowitz, S B Miller, J Stone, E Hanson, J Palefsky.   

Abstract

OBJECTIVES: The objectives of this study were to describe the early natural history of human papillomavirus (HPV) infection by examining a cohort of young women positive for an HPV test and to define within this cohort (1) the probability of HPV regression, (2) the risk of having a squamous intraepithelial lesion, and (3) factors that were associated with HPV regression. STUDY
DESIGN: The study was a cohort analytic design. An inception cohort of 618 women positive for HPV participated. HPV testing, cytologic evaluation, and colposcopic evaluation were performed at 4-month intervals. HPV testing was characterized for two groups: low risk (five types rarely associated with cancers) and high risk (nine types most commonly associated with cancers).
RESULTS: Estimates provided by Kaplan-Meier curves showed that approximately 70% of women were found to have HPV regression by 24 months. Women with low-risk HPV type infections were more likely to show HPV regression than were women with high-risk HPV type infections (log rank test p = 0.002). The relative risk for the development of high-grade squamous intraepithelial lesion (HSIL) was 14.1 (95% confidence interval: 2.3, 84.5) for women with at least three positive tests for high-risk HPV preceding the development of the HSIL compared with that for women with negative tests for high-risk HPV. However, 88% of women with persistent positive HPV tests have not had HSIL to date. No factors associated with high-risk HPV type regression were identified except for a negative association with an incident history of vulvar condyloma (relative risk = 0.5 [95% confidence interval: 0.3 to 0.8]).
CONCLUSION: Most young women with a positive HPV test will become negative within a 24-month period. Persistent positive tests with oncogenic HPV types represented a significant risk for the development of HSIL. However, we found that most young women with persistent positive HPV tests did not have cytologically perceptible HSIL over a 2-year period. Factors thought to be associated with the development of HSIL were found not to be important in HPV regression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506641     DOI: 10.1016/s0022-3476(98)70445-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  120 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  With urine-based screening, do sexually active adolescent girls still need annual pelvic examinations? Yes: pelvic examination continues to play a key role.

Authors:  J A Kahn
Journal:  West J Med       Date:  2000-11

3.  With urine-based screening, do sexually active adolescent girls still need annual pelvic examinations? No: recommending annual exams is not evidence based.

Authors:  M A Shafer
Journal:  West J Med       Date:  2000-11

4.  Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously?

Authors:  L Brabin
Journal:  BMJ       Date:  2001-08-18

5.  Distinct clinico-immunological profile of patients infected with human papilloma virus genotypes 6 and 11.

Authors:  Manjula Singh; Deepshi Thakral; Hemanta Kumar Kar; Narayan Rishi; Prafulla Kumar Sharma; Dipendra Kumar Mitra
Journal:  Virusdisease       Date:  2017-05-20

6.  Oestrogen receptor transcripts associated with cervical human papillomavirus infection.

Authors:  M L Shew; R McGlennen; N Zaidi; M Westerheim; M Ireland; S Anderson
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

7.  High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger.

Authors:  Yuanchun Xu; Jorge Dotto; Yiang Hui; Kara Lawton; Kevin Schofield; Pei Hui
Journal:  Int J Clin Exp Pathol       Date:  2008-07-25

8.  Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

Authors:  Shih-Min Huang; D J McCance
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer.

Authors:  S L Sudenga; S Shrestha
Journal:  Int J Infect Dis       Date:  2013-02-27       Impact factor: 3.623

10.  HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border.

Authors:  Maria E Fernandez; Sheryl A McCurdy; Sarah R Arvey; Sandra K Tyson; Daisy Morales-Campos; Belinda Flores; Bernardo Useche; Lisa Mitchell-Bennett; Maureen Sanderson
Journal:  Ethn Health       Date:  2009-12       Impact factor: 2.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.